Literature DB >> 12445337

Endothelin receptor antagonists and cerebral vasospasm: an update.

Michael Chow1, Aaron S Dumont, Neal F Kassell.   

Abstract

THIS REVIEW UPDATES: the current status of endothelin receptor antagonists in the treatment of cerebral vasospasm. Recent preclinical and clinical studies are reviewed, as well as clinical trials for other medical indications. Some of the newer endothelin receptor antagonists are also examined.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12445337

Source DB:  PubMed          Journal:  Neurosurgery        ISSN： 0148-396X            Impact factor:   4.654


  19 in total

Review 1.  Brain ischemia in patients with intracranial hemorrhage: pathophysiological reasoning for aggressive diagnostic management.

Authors:  Daniel Naranjo; Michal Arkuszewski; Wojciech Rudzinski; Elias R Melhem; Jaroslaw Krejza
Journal:  Neuroradiol J       Date:  2013-12-18

Review 2.  Current management of delayed cerebral ischemia: update from results of recent clinical trials.

Authors:  Shakira Brathwaite; R Loch Macdonald
Journal:  Transl Stroke Res       Date:  2013-12-13       Impact factor: 6.829

Review 3.  Unfractionated heparin: multitargeted therapy for delayed neurological deficits induced by subarachnoid hemorrhage.

Authors:  J Marc Simard; David Schreibman; E Francois Aldrich; Bernadette Stallmeyer; Brian Le; Robert F James; Narlin Beaty
Journal:  Neurocrit Care       Date:  2010-12       Impact factor: 3.210

Review 4.  Application and implementation of selective tissue microdissection and proteomic profiling in neurological disease.

Authors:  Jay Jagannathan; Jie Li; Nicholas Szerlip; Alexander O Vortmeyer; Russell R Lonser; Edward H Oldfield; Zhengping Zhuang
Journal:  Neurosurgery       Date:  2009-01       Impact factor: 4.654

5.  Intra-arterial nimodipine for the treatment of symptomatic cerebral vasospasm after aneurysmal subarachnoid hemorrhage: preliminary results.

Authors:  Alessandra Biondi; Giuseppe K Ricciardi; Louis Puybasset; Lamine Abdennour; Marcello Longo; Jacques Chiras; Rémy Van Effenterre
Journal:  AJNR Am J Neuroradiol       Date:  2004 Jun-Jul       Impact factor: 3.825

6.  Intraarterial nimodipine infusion to treat symptomatic cerebral vasospasm after aneurysmal subarachnoid hemorrhage.

Authors:  Jong Hoon Kim; In Sung Park; Kyung Bum Park; Dong-Ho Kang; Soo Hyun Hwang
Journal:  J Korean Neurosurg Soc       Date:  2009-09-30

7.  High-dose bosentan in the prevention and treatment of subarachnoid hemorrhage-induced cerebral vasospasm: an open-label feasibility study.

Authors:  Raul G Nogueira; Michael J Bodock; Walter J Koroshetz; Mehmet A Topcuoglu; Bob S Carter; Christopher S Ogilvy; Johnny C Pryor; Ferdinando S Buonanno
Journal:  Neurocrit Care       Date:  2007       Impact factor: 3.210

Review 8.  Endothelins in cardiovascular biology and therapeutics.

Authors:  Neeraj Dhaun; David J Webb
Journal:  Nat Rev Cardiol       Date:  2019-08       Impact factor: 32.419

9.  Effect of clazosentan in patients with aneurysmal subarachnoid hemorrhage: a meta-analysis of randomized controlled trials.

Authors:  Xiang Wang; Yi-Ming Li; Wei-Qing Li; Cheng-Guang Huang; Yi-Cheng Lu; Li-Jun Hou
Journal:  PLoS One       Date:  2012-10-17       Impact factor: 3.240

Review 10.  Endothelin.

Authors:  Anthony P Davenport; Kelly A Hyndman; Neeraj Dhaun; Christopher Southan; Donald E Kohan; Jennifer S Pollock; David M Pollock; David J Webb; Janet J Maguire
Journal:  Pharmacol Rev       Date:  2016-04       Impact factor: 25.468
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.